| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | ||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-28,538 | -25,084 | 0 | 0 | 0 | ||
Adjustments to reconcile net loss to net cash (used in) provided by operating activities | ||||||
Depreciation and amortization | ||||||
5,097 | 4,748 | 0 | 0 | 0 | ||
Noncash operating lease cost | ||||||
1,083 | 982 | 0 | 0 | 0 | ||
Stock-based compensation expense | ||||||
5,498 | 4,858 | 0 | 0 | 0 | ||
Change in fair value of convertible preferred stock warrant liability | ||||||
- | 1,403 | 0 | 0 | 0 | ||
Accretion of noncash interest and debt reduction | ||||||
- | 156 | 0 | 0 | 0 | ||
Other | ||||||
-350 | -427 | 0 | 0 | 0 | ||
Changes in operating assets and liabilities | ||||||
Accounts receivable | ||||||
2,485 | -1,069 | 0 | 0 | 0 | ||
Inventory and other deferred costs | ||||||
3,554 | 1,174 | 0 | 0 | 0 | ||
Prepaid expenses and other current assets | ||||||
2,273 | 2,559 | 0 | 0 | 0 | ||
Accounts payable | ||||||
4,603 | 1,398 | 0 | 0 | 0 | ||
Accrued and other current liabilities | ||||||
1,141 | 1,999 | 0 | 0 | 0 | ||
Contract liabilities | ||||||
-9,908 | -6,920 | 0 | 0 | 0 | ||
Other long-term liabilities | ||||||
-899 | -1,076 | 0 | 0 | 0 | ||
Net cash (used in) provided by operating activities | ||||||
-26,778 | -18,069 | 0 | 0 | 0 | ||
Cash flows from investing activities: | ||||||
Purchases of available-for-sale debt securities | ||||||
0 | - | - | - | - | ||
Proceeds from maturities of available-for-sale debt securities | ||||||
0 | - | - | - | - | ||
Purchases of property and equipment | ||||||
7,498 | 8,382 | 0 | 0 | 0 | ||
Net cash used in investing activities | ||||||
-80,654 | -81,579 | 0 | 0 | 0 | ||
Cash flows from financing activities: | ||||||
Payments of costs related to initial public offering | ||||||
- | 4,197 | 0 | 0 | 0 | ||
Proceeds from borrowings | ||||||
- | 20,000 | 0 | 0 | 0 | ||
Payments of borrowing costs | ||||||
- | 490 | 0 | 0 | 0 | ||
Repayments under borrowing arrangements | ||||||
- | 25,000 | 0 | 0 | 0 | ||
Proceeds from exercise of stock options | ||||||
682 | 712 | 0 | 0 | 0 | ||
Net cash provided by financing activities | ||||||
120,885 | 134,948 | 0 | 0 | 0 | ||
Effect of exchange rates on cash flows and cash equivalents | ||||||
0 | - | - | - | 0 | ||
Net change in cash and cash equivalents | ||||||
0 | - | - | - | 0 | ||